首页 | 本学科首页   官方微博 | 高级检索  
     

临界可切除胰腺癌的诊疗策略
引用本文:刘江|吉顺荣|徐近|虞先濬. 临界可切除胰腺癌的诊疗策略[J]. 中国普通外科杂志, 2017, 26(9): 1089-1092
作者姓名:刘江|吉顺荣|徐近|虞先濬
作者单位:(复旦大学附属肿瘤医院 胰腺外科/复旦大学上海医学院肿瘤学系/上海市胰腺肿瘤研究所|上海 200032)
摘    要:胰腺癌早期诊断困难,80%的患者就诊时已发生局部进展或远处转移。目前,手术切除仍是胰腺癌患者获得长期生存的唯一方法。近年来,胰腺癌综合治疗水平较前有所提高。针对临界可切除胰腺癌进行新辅助治疗,可以达到降期,甄别人群,筛选潜在获益人群进行手术的目的。合理选择有效化疗方案,恰当选择手术时机,能进一步提高胰腺癌的切除率,从而延长该类高危人群的生存期。

关 键 词:胰腺肿瘤/诊断;胰腺肿瘤/治疗;放化疗,辅助
收稿时间:2017-08-01
修稿时间:2017-08-15

Diagnosis and treatment strategies for borderline resectable pancreatic cancer
LIU Jiang,JI Shunrong,XU Jin,YU Xianjun. Diagnosis and treatment strategies for borderline resectable pancreatic cancer[J]. Chinese Journal of General Surgery, 2017, 26(9): 1089-1092
Authors:LIU Jiang  JI Shunrong  XU Jin  YU Xianjun
Affiliation:(Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center/Department of Oncology, Shanghai Medical College, Fudan Univerisity/Shanghai Research Institute for Pancreatic Cancer, Shanghai 200032, China)
Abstract:Pancreatic cancer is difficult to diagnose at an early stage, with about 80% of patients having local invasion or distant metastasis at the initial consultation. At present, surgical resection remains the only hope for long-term survival in patients with pancreatic cancer. The level of comprehensive treatment of pancreatic cancer has somewhat improved over the past few years. In borderline resectable pancreatic cancer, the use of neoadjuvant therapy may achieve the goal of tumor downstaging, and screening and selecting potential patients for surgery. Proper selection of chemotherapy regimen and appropriate choice of surgery timing can further improve the resection rate of pancreatic cancer, and thereby prolong the survival time in this high-risk population.
Keywords:Pancreatic Neoplasms/diag   Pancreatic Neoplasms/therapy   Chemoradiotherapy, Adjuvant
本文献已被 CNKI 等数据库收录!
点击此处可从《中国普通外科杂志》浏览原始摘要信息
点击此处可从《中国普通外科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号